Previous 10 | Next 10 |
2024-01-31 17:14:07 ET Trinity Biotech plc (TRIB) M&A and Q3 2023 Results Conference Call January 31, 2024 08:30 AM ET Company Participants Eric Ribner - Managing Director, LifeSci Advisors John Gillard - Chief Executive Officer Des Fitzgerald - Chief Financi...
2024-01-31 08:03:11 ET DENVER, Colo., Jan. 31, 2023 ( www.247marketnews.com )- Trinity Biotech plc (NASDAQ: TRIB) announced, this morning, its results for the quarter ended September 30, 2023, including business updates. Additionally, it published two press releases. Trinity Biotech...
2024-01-31 07:36:08 ET More on Trinity Biotech Financial information for Trinity Biotech Read the full article on Seeking Alpha For further details see: Trinity Biotech partners with Bayer to launch CGM device in China and India
2024-01-31 07:28:19 ET More on Trinity Biotech Financial information for Trinity Biotech Read the full article on Seeking Alpha For further details see: Trinity Biotech reports Q3 results
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) today announced the Company’s results for the quarter ended September 30, 2023. Business Updates and Strategic Priorities In December 2023, the Company announced the promotion of John Gillard ...
DUBLIN, Ireland, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”) today announced that it has entered into a non-binding Letter of Intent with Bayer for the launch of a Continuous Glucose Monitoring (“CGM”) biosensor device in China ...
-Repositioning to a rapidly expanding biosensor market with potential for significant growth for the company as part of a revised strategy under our new management -Upfront payment of $12.5 million cash and 9 million ADSs -Strengthened investment relationship with Perceptive Advis...
DUBLIN, Ireland, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM E...
DUBLIN, Ireland, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announces it has begun commercial shipments to Kenya of its...
2023-12-18 16:39:51 ET More on Trinity Biotech Trinity Biotech plc (TRIB) Q2 2023 Earnings Call Transcript Financial information for Trinity Biotech For further details see: Trinity Biotech promotes finance chief John Gillard to CEO
News, Short Squeeze, Breakout and More Instantly...
Trinity Biotech plc Company Name:
TRIB Stock Symbol:
NASDAQ Market:
DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, today announced results for the quarter ended December 31, 2023 and fisca...
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (NASDAQ:TRIB) (the "Company"), a leading developer and manufacturer of d...
DUBLIN, Ireland, March 28, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will report financial results for the fourth quarter and fiscal...